|
|||||||
|
NDC# 49730-111-30 - 0.2mg/hr | NDC# 49730-112-30 - 0.4mg/hr | NDC# 49730-113-30 - 0.6mg/hr In addition to Hercon's Nitroglycerin Transdermal products, the Company is currently developing NDA & ANDA products for client pharmaceutical companies. For more information on Hercon’s Nitroglycerin Transdermal Systems, please contact our sales and marketing representatives. View our Patient Package Insert (PDF) | Authorized Distributors (PDF) |
|